Maroney Dawn Christine sold $586K of ALHC
Maroney Dawn Christine (President) sold 30,000 shares of Alignment Healthcare, Inc. (ALHC) at $19.55 ($0.59M total) on 2026-06-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the officer’s open-market sale of 30,000 shares at a stated price, with holdings after the transaction and confirmation of a pre-arranged 10b5-1 plan.
Market read
Provides a concrete, same-day insider sale datapoint that can influence short-term sentiment, though 10b5-1 reduces interpretive weight.
What to watch
Traders may over-weight insider sales; the key incremental information here is the exact share count, price, and that the plan is pre-arranged.
Background
The article is an SEC Form 4 insider transaction disclosure for Alignment Healthcare, Inc. (ALHC).
Ticker impact
Alignment Healthcare President Maroney Dawn Christine sold 30,000 shares in an open-market transaction at $19.5475 on 2026-06-15 under a 10b5-1 plan.
Likely limited near-term impact; any reaction should be muted given the 10b5-1 pre-arranged nature.
The filing provides a concrete transaction size and price, but the presence of a pre-arranged 10b5-1 plan typically lowers interpretive value versus discretionary selling.
Market effects
No sector-level read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.
Key entities
- issuerAlignment Healthcare, Inc.
Subject of the Form 4 insider transaction disclosure (ALHC).
- insiderMaroney Dawn Christine
President and reporting officer who sold 30,000 shares under a 10b5-1 plan.
